Aeterna Zentaris Inc (AEZS)

Trade AEZS now with
6/25/2020 8:17:35 AM Aeterna Zentaris Enters Exclusive Distribution And Related Quality Agreement With Megapharm
6/8/2020 8:12:53 AM Aeterna Zentaris Regains Compliance With Minimum Bid Price For Continued Listing On Nasdaq Capital Market
4/6/2020 9:12:25 AM Aeterna Zentaris Announces Positive Results For First Pediatric Study Of Macimorelin
1/27/2020 8:39:05 AM Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement For Continued Listing
8/20/2019 11:19:13 PM Aeterna Zentaris Director Jonathan Pollack Resigns
1/16/2019 9:07:46 AM Aeterna Zentaris Says European Medicines Agency Grants Marketing Authorization For Macimorelin
11/19/2018 8:09:48 AM Aeterna Zentaris Gets Positive CHMP Opinion Of Macimorelin For Diagnosis Of Adult Growth Hormone Deficiency
9/25/2018 8:03:25 AM Aeterna Zentaris Appoints Leslie Auld As CFO
3/28/2018 7:11:12 AM Aeterna Zentaris Posts FY Net Loss Of $16.8 Mln On $0.9 Mln Revenues
3/5/2018 4:08:38 PM Aeterna Zentaris Appoints James Clavijo As CFO
3/5/2018 7:46:55 AM Aeterna Zentaris Updates On Previously Disclosed Class Action Lawsuit
1/17/2018 7:04:36 AM Aeterna Zentaris Signs Licensing And Assignment Deal With Strongbridge For Macrilen In U.S. And Canada
1/7/2018 9:50:22 AM New Drugs Approved In December
3/29/2012 10:58:40 AM RBC Capital Markets Is Increasing AEterna Zentaris Inc (AEZS) Q4 12 Rev. Estimate To 10.8 M From 10.2 M